The number of funding disclosures in 2020 demonstrates investment interest in orthopedics’ smaller companies and novel technologies even amongst COVID-19s hit on the industry.
Eeric Truumees, M.D., First Vice President of NASS’ Board of Directors, is optimistic that the online virtual annual meeting event in October will allow attendees to benefit from broader input in smaller doses.
DUROLANE injection treats knee osteoarthritis in patients who have failed to respond adequately to conservative non-pharmacological therapy or analgesics.